InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Farwell Wildon, Directeur Médical. Officer active across 1 companies, notably Dyne Therapeutics, Inc.. In total, 5 reports have been recorded. Total volume traded: €48k. The latest transaction was filed on 14 June 2022 — Disposition. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€3,167668 shares@ €4.74110.0001% mcap6.2% of flow
Common Stock
SEC:0001209191-22-037145:0·
€5,073640 shares@ €7.92630.0002% mcap9.9% of flow
Common Stock
SEC:0001209191-22-018533:0·
€43,1895,617 shares@ €7.6890.0015% mcap84.0% of flow
Common Stock
SEC:0001209191-22-015901:0·
022,307 shares0
Common Stock
SEC:0001209191-21-069422·
022,307 shares0
Common Stock
SEC:0001209191-21-069422:0·
5 of 5 declarations
About Farwell Wildon
Wildon Farwell is the Chief Medical Officer at Dyne Therapeutics, Inc. He oversees the company's medical and research activities. His expertise is essential for developing innovative therapeutic solutions.
